Skip to content

Observational study on Prevalence of neuropathic pain in advanced cancer patients

Prevalence of neuropathic pain and associated factors in patients with advanced malignancy in outpatient specialist palliative clinic in a tertiary care cancer centre in India: A cross-sectional observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084461
Enrollment
679
Registered
2025-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age more than 18 years and willing to participate 2.Able to communicate and understand English or Hindi or Marathi or Bengali 3.Able to give written informed consent for questionnaire administration 4.Diagnosed case of any advanced malignancy 5.Patient presenting with pain

Exclusion criteria

Exclusion criteria: 1.Unstable medical condition requiring emergency treatment 2.Pre-existing Psychiatric disorder or cognitive impairment preventing patients from comprehending questionnaire 3.Pain unrelated to cancer according to clinicians discretion

Design outcomes

Primary

MeasureTime frame
To assess the prevalence of cancer neuropathic pain in patients with advanced malignancy using IASP grading system for neuropathic painTimepoint: baseline

Secondary

MeasureTime frame
1.To identify the factors associated with cancer neuropathic pain in patients with advanced malignancy using ESAS-R, PHQ 9 & GAD7 2.Understand the impact of neuropathic pain on quality of life using EORTC QLQ-C15-PAL 3.Pain Quality Descriptors-Yes/No I. Burning II. Pricking III. Shooting IV. Electrical/Shock like V. Throbbing VI. Radiating VII. Numbing 4.Document current patterns of management of cancer neuropathic pain as documented on EMR. Timepoint: baseline

Countries

India

Contacts

Public ContactDr Raghu S Thota

TATA MEMORIAL HOSPITAL

ayshapathari@gmail.com7356680560

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026